Mental Health Disorders (Credit: Canva)
How often do you hear people calling each other "psychopath"? Or how often do you witness people labelling themselves as "bipolar" or "depressed"? Quite frequently. Right? These are names of some serious, often life-threatening mental disorders which have been included in common vocabulary. Ayushi Jolly, a PhD scholar opined that "mental health disorders are not adjective to be thrown around."
Obsessive Compulsive Disorder (OCD)
Today, many people who are organized and prioritize santitation and hygeine, label themselves as suffering from OCD. However, in psychology, OCD is a long-lasting disorder in which a person experiences uncontrollable and recurring thoughts (obsessions), engages in repetitive behaviours (compulsions), or both. This condition can significantly impair daily functioning, leading to severe anxiety and distress. Without proper treatment, it can escalate, affecting relationships, work, and overall quality of life.
Depression
"I am so depressed, I act like it's my birthday everyday," these are lyrics from a chart-topping Taylor Swift song. However, the singer-songwriter has never been diagnosed for the same. Similarly, people throw away the term even at the slightest discomfort. But, this mental health disorder is life-thretening, serious mood disorder. It causes severe symptoms that affect how a person feels, thinks, and handles daily activities, such as sleeping, eating, or working. Note, to be diagnosed with depression, the symptoms must be present for at least 2 weeks.
Attention Deficit Disorder (ADD)
Any person who is high on energy and gets distracted easily could be heard saying "I'm suffering from ADD." In reality, ADD is a type of attention-deficit/hyperactivity disorder (ADHD) that's characterized by problems with concentration and focus. ADHD is a developmental disorder that can affect a person's daily life, including their ability to perform at school or work and their social relationships.
Bipolar Personality Disorder
Broke up with your partner? Chances are you'll end up calling them bipolar. The terms has also been used in various films and songs, sans the knowledge of it's seriousness. Formerly known as manic-depressive illness or manic depression, this condition is a lifelong mood disorder that causes intense shifts in mood, energy levels, thinking patterns and behavior. A person suffering from this disorder witnesses intense shifts in mood, energy levels, thinking patterns and behavior, for long periods of time.
Paranoid Personality Disorder (PPD)
Being "paranoid" has become more like a negative adjective among teens and young adults. However, a person who suffers from this condition is incapable of maintaining succesful relationahips. Paranoid Personality Disorder (PPD) is a group of personality disorders categorised under "Cluster A". A person with PPD thinks in odd or eccentric ways, and suffers from unrelenting mistrust or suspicion of others, even when there is no reason to be suspicious. This disorder usually begins in early adulthood and appears more common in men than women. People with PPD are always on guard, believing that others are constantly trying to demean, harm, or threaten them. People with this disorder also doubt the commitment, loyalty, or trustworthiness of others. PPD patients also might have difficulty relaxing.
Credit: Canva
Atrial fibrillation (AFib) is an irregular and often very rapid heart rhythm, also called an arrhythmia and can create blood clots in the heart, which can increase your risk of having a stroke by five times.
When a person has AFib, the normal beating in the upper chambers of the heart (the two atria) is irregular and blood doesn't flow as well as it should from the atria to the lower chambers of the heart (the two ventricles).
Common symptoms include palpitations (the feeling that your heart is racing, pounding, fluttering or like you have missed heartbeats), chest pain, finding it harder to exercise, tiredness, shortness of breath, dizziness or feeling faint. However, a more severe symptom is a stroke.
Tucked inside the heart is a tiny pouch called the left atrial appendage. When the heart beats erratically, blood can pool and sit still in this pouch instead of flowing normally and still blood tends to clot. If one of those clots breaks free and travels to the brain, it can block blood flow and cause a stroke.
But researchers have now found new technique, in which a magnetically guided liquid is injected into the heart can harden and permanently seal the left atrial appendage from the inside. Early tests in rats and pigs suggest that this method could one day lower the risk of stroke in people with atrial fibrillation.
Based on this technique, researchers inject a magnetically responsive liquid, sometimes called a magnetofluid, directly into the left atrial appendage through a catheter.
Once inside the cavity, an external magnetic field helps guide and hold the fluid in place, so it fills the entire appendage, even against the force of circulating blood.
Within minutes, the liquid reacts with water in the blood and transforms into a soft "magnetogel" that seals off the cavity. Additionally, as the material begins as a liquid, it can adapt precisely to the highly irregular shape of each patient's left atrial appendage.
The death rate from AFib as the primary or a contributing cause of death has been rising for more than two decades.
Over 454,000 people with AFib are hospitalized in the US each year, out of which 158,000 die of the cause. It is estimated that 12.1 million people in the US will have AFib in the US will have AFib by 2050.
Risk factors for AFib include:
Treatment for AFib includes medications to control the heart's rhythm and rate, therapy to shock the heart back to a regular rhythm and procedures to block faulty heart signals.
A person with atrial fibrillation also may have a related heart rhythm disorder called atrial flutter. The treatments for AFib and atrial flutter are similar.
Experts recommend following the below to reduce yor risk of stroke or developing AFib and maintaining heart health:
Credit: Canva, Canada Insulin
Orforglipron, a new daily pill, may be more effective than existing oral treatments for weight loss and blood sugar control than semaglutide, according to a recent clinical trial.
Semaglutide belongs to a group of drugs known as GLP-1 medications, known to mimic a natural hormone that helps regulate appetite, slow digestion, and control blood sugar. The drug is commonly sold under the brand names Wegovy and Ozempic.
Despite being highly effective, semaglutide usually needs to be injected and requires refrigeration, which can make it inconvenient and harder to access for some patients. Additionally, the drug also carries a high price point.
However, in a 52-week trial involving people with Type 2 Diabetes, orforglipron was found to lower average blood sugar levels more than oral semaglutide and also led to greater weight loss.
Participants taking orforglipron lost around up to eight kilograms on average, compared to about five kilograms with semaglutide. Morever, orforglipron is a once-daily pill that does not require injections or cold storage.
But the study also found that orforglipron caused more side effects, particularly digestive issues like nausea and diarrhea. Yet scientists believe it may still be a better alternative to semaglutide as its easier and cheaper to produce than peptide-based drugs like semaglutide.
They also noticed that the drug absorbed more efficiently by the body and does not require strict timing around meals, unlike current oral versions of semaglutide.
READ MORE: Alkem Laboratories Launches Cheapest Semaglutide Injection In India
The first thing to remember here is that Ozempic is a brand-name medicine that contains semaglutide as its active ingredient. Semglutide is the synthetic version of GLP-1—a natural hormone produced in the intestines that regulates blood sugar, appetite, and digestion. Now, every time you eat, your body produces various hormones, including GLP-1. These are called Post nutrition hormones, and help you absorb the energy you just consumed.
GLP-1 travels to your pancreas, prompting it to produce insulin. It also travels to the hypothalamus in your brain, which gives you the feeling of being full or satiated. Ozempic imitates this hormone, thereby, silencing the food chatter in the brain. Interestingly, for some people this food chatter is really quiet ( people with low appetite) and for others it is an outbrurst, (people who generally binge eat.) So with Ozempic, silencing this self-talk in the brain, people tend to lose their appetite and eventually weight.
However, it is important to note that losing weight includes not just fat but muscle as well. Losing too much muscle can lead to reduced strength and a shorter life span. Notably, records show that most people who start taking them stop it at 12 weeks; therefore, it is important for some but not for others.
As reiterated by doctors and health care experts, Ozempic is a drug that is tasked to help diabetic patients manage their blood sugar levels and weight. However, recent research has shown its effectiveness in mitigating various addictions like alcohol and drugs by inhibiting hormones. But what people ignore are its side effects, which include:
Credit: Canva
People with blood type B, either positive or negative, are 28 percent more likely to develop Type 2 diabetes, according to a 2024 BMC Medicine study.
Human blood is categorized into eight main groups based on the sugars and proteins, or lack thereof, present on the surface of your red blood cells.
A, B, and AB types are based on the presence of antigens, sugar molecules that can trigger an immune response. O-type blood has no A or B antigens. Meanwhile, Rhesus (Rh) factors are proteins that determine blood compatibility and give your blood its positive or negative designation.
According to a group of Chinese researchers, who conducted a thorough umbrella review of 270 studies, the strongest link between a blood group and Type 2 diabetes was between those with a B blood group.
The researchers also didn't examine what might drive this increased risk. A 2025 study suggests that the gut microbiome may be involved; however, further investigation is needed.
However, the results do suggest that there's a real, tangible association between blood type and Type 2 diabetes – one that people can factor into how they think about their own risk.
Type 2 diabetes (T2D) occurs when blood sugar (glucose) remains consistently high. Normal blood sugar levels fall between 70 and 99 milligrams per deciliter (mg/dL). If undiagnosed, Type 2 diabetes often shows levels of 126 mg/dL or more.
T2D happens because the pancreas doesn’t produce enough insulin, the body can’t use insulin effectively, or a combination of both. This differs from Type 1 diabetes, which arises when the immune system attacks the pancreas, leaving the body unable to produce insulin at all.
Type 2 diabetes is widespread. Over 37 million people in the US have diabetes (around 1 in 10), with 90–95 percent of cases being T2D. Globally, it affects roughly 6.3 percent of the population. While it’s most common in adults over 45, younger adults and even children can develop it.
The American Diabetes Association recommends the following ranges for adults with type 1 or type 2 diabetes and children with type 2 diabetes:
Recommended Blood Sugar Range
Fasting (before eating): 80 to 130 mg/dL
1 to 2 hours after meal: Lower than 180 mg/dL
T2D has complex causes, but genes play a significant role. If one biological parent has T2D, your lifetime risk is around 40 percent, and if both parents do, it rises to 70%. Scientists have identified over 150 DNA variations linked to T2D risk, some increase the chance of insulin resistance or reduced insulin production, while others influence obesity risk. These genetic factors interact with lifestyle and health habits to determine overall risk.
Doctors use several blood tests to confirm T2D:
© 2024 Bennett, Coleman & Company Limited